Medicare Enrolled
Dr. Andrew Caldwell, DO
Family Medicine · Sanford, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Caldwell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caldwell?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Caldwell
Dr. Andrew Caldwell is a family medicine specialist in Sanford, NC, with 12 years of NPI registration. Based on federal Medicare data, Dr. Caldwell performed 3,669 Medicare services across 1,546 unique beneficiaries.
Between the years covered by Open Payments, Dr. Caldwell received a total of $11,288 from 67 pharmaceutical and/or device companies across 675 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Caldwell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 5% volume in NC
$11,288 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,669
Medicare services
Top 5% in NC for family medicine
1,546
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~306 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,560 | $18 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
725 | $74 | $255 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
231 | $124 | $245 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
227 | $78 | $144 |
| Annual depression screening | 196 | $18 | $39 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
129 | $9 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
128 | $29 | $52 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
112 | $76 | $96 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
82 | $1 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $53 | $173 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
54 | $72 | $278 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $125 | $341 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
22 | $29 | $51 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
20 | $281 | $527 |
| Annual alcohol misuse screening, 5 to 15 minutes | 20 | $18 | $39 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
18 | $38 | $250 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
15 | $20 | $49 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $156 | $433 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
12 | $2 | $13 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,288
Total received (2018-2024)
Avg $1,613/year across 7 years
Top 4% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
675
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,982 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$306 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,694
2023
$1,870
2022
$1,744
2021
$1,912
2020
$1,475
2019
$1,843
2018
$750
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$520
Lilly USA, LLC
$221
Abbott Laboratories
$95
AstraZeneca Pharmaceuticals LP
$71
Exact Sciences Corporation
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Merck Sharp & Dohme LLC
$61
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Amgen Inc.
$59
E.R. Squibb & Sons, L.L.C.
$56
Sumitomo Pharma America, Inc.
$55
Mylan Specialty L.P.
$52
Ardelyx, Inc.
$41
Phathom Pharmaceuticals, Inc.
$34
Insulet Corporation
$34
PFIZER INC.
$32
GlaxoSmithKline, LLC.
$28
Otsuka America Pharmaceutical, Inc.
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
AIMMUNE THERAPEUTICS, INC.
$21
IRONWOOD PHARMACEUTICALS, INC
$18
ABBVIE INC.
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Astellas Pharma US Inc
$14
Phadia US Inc.
$14
Top 3 companies account for 49.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,804
Lilly USA, LLC
$789
AstraZeneca Pharmaceuticals LP
$695
Boehringer Ingelheim Pharmaceuticals, Inc.
$625
AbbVie Inc.
$542
Amarin Pharma Inc.
$491
SANOFI-AVENTIS U.S. LLC
$476
Astellas Pharma US Inc
$381
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$363
Merck Sharp & Dohme LLC
$248
PFIZER INC.
$244
Abbott Laboratories
$216
Mylan Specialty L.P.
$203
Amgen Inc.
$203
GlaxoSmithKline, LLC.
$175
Janssen Pharmaceuticals, Inc
$163
Insulet Corporation
$158
Allergan, Inc.
$154
Sunovion Pharmaceuticals Inc.
$152
Exact Sciences Corporation
$125
Sumitomo Pharma America, Inc.
$124
Mannkind Corporation
$124
Merck Sharp & Dohme Corporation
$119
Nestle HealthCare Nutrition Inc.
$114
Biohaven Pharmaceuticals, Inc.
$111
ITI, Inc.
$96
ABBVIE INC.
$96
Novartis Pharmaceuticals Corporation
$94
Bayer Healthcare Pharmaceuticals Inc.
$94
Esperion Therapeutics, Inc.
$68
Allergan Inc.
$66
Otsuka America Pharmaceutical, Inc.
$66
Daiichi Sankyo Inc.
$58
E.R. Squibb & Sons, L.L.C.
$56
Genentech USA, Inc.
$52
Shire North American Group Inc
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Ironwood Pharmaceuticals, Inc
$42
Ardelyx, Inc.
$41
Neos Therapeutics, LP
$35
Phathom Pharmaceuticals, Inc.
$34
Biohaven Pharmaceutical Holding Company Ltd.
$34
Eisai Inc.
$31
Dova Pharmaceuticals
$30
Mission Pharmacal Company
$28
Clarus Therapeutics Inc.
$27
Celgene Corporation
$25
UCB, Inc.
$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
AIMMUNE THERAPEUTICS, INC.
$21
Bausch Health US, LLC
$20
Antares Pharma, Inc.
$19
IRONWOOD PHARMACEUTICALS, INC
$18
Aytu Bioscience, Inc
$16
Currax Pharmaceuticals LLC
$16
IDORSIA PHARMACEUTICALS US INC
$16
Almatica Pharma LLC
$15
Medtronic MiniMed, Inc.
$15
Collegium Pharmaceutical, Inc.
$15
EISAI INC.
$15
Hikma Pharmaceuticals USA
$14
Phadia US Inc.
$14
Lexicon Pharmaceuticals, Inc.
$13
Xeris Pharmaceuticals, Inc.
$13
Cranial Technologies, Inc
$13
Dexcom, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · ANORO ELLIPTA · Aciphex · Adzenys XR-ODT · Aimovig · BELSOMRA · BREZTRI · BYDUREON · BYSTOLIC · CAMZYOS · CAPLYTA · CHANTIX · CONTRAVE · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · Doc Band · Doptelet · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Ferralet · GARDASIL · GARDASIL 9 · GEMTESA · GLYXAMBI · GVOKE HYPOPEN · IBSRELA · INJECTAFER · INVOKANA · ImmunoCAP · Inpefa · JANUVIA · JARDIANCE · JATENZO · Kerendia · LEQVIO · LINZESS · LO LOESTRIN FE · LONHALA MAGNAIR · LOREEV XR · LYRICA · Linzess · Livalo · MIGRANAL · MOUNJARO · MYRBETRIQ · Minimed 630G · Mitigare · Morphabond ER · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · Nayzilam · ORIAHNN · ORILISSA · OTREXUP · Omnipod · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · PROQUAD · Proclaim Family of SCS IPGs · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · ROTATEQ · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · UBRELVY · Uribel · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xofluza · YUPELRI · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in NC.
Geographic Context
Family medicine physicians within 10 mi
149
Per 100K population
230.8
County median income
$63,060
Nearest hospital
CENTRAL CAROLINA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Caldwell is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NC), with low-engagement industry engagement in the top 4% of NC peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Caldwell experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Caldwell performed 1,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caldwell receive payments from pharmaceutical companies?
Yes. Dr. Caldwell received a total of $11,288 from 67 companies across 675 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caldwell's costs compare to other family medicine physicians in Sanford?
Dr. Caldwell's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caldwell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Sanford
Browse family medicine physicians in Sanford ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NC
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NC
Which NC family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology